rigevidon
gedeon richter plc - etinilestradiolis/levonorgestrelis - dengtos tabletės - 30 µg/150 µg - levonorgestrel and ethinylestradiol
rigevidon
limedika, uab - levonorgestrelis/etinilestradiolis - dengtos tabletės - 30 µg/150 µg - levonorgestrel and ethinylestradiol
vellofent
aziende chimiche riunite angelini francesco - a.c.r.a.f. s.p.a. - fentanilis - poliežuvinės tabletės - 533 µg; 400 µg; 267 µg; 133 µg; 67 µg; 800 µg - fentanyl
gracial
aspen pharma trading limited - dezogestrelis/etinilestradiolis+dezogestrelis/etinilestradiolis - tabletės - 25 µg/40 µg + 125 µg/30 µg - desogestrel and ethinylestradiol
belara
gedeon richter plc - etinilestradiolis/chlormadinono acetatas - plėvele dengtos tabletės - 0,03 mg/2 mg - chlormadinone and ethinylestradiol
cilest
tojaris projektai, uab - norgestimatas/etinilestradiolis - tabletės - 250 µg/35 µg - norgestimate and ethinylestradiol
cilest
limedika, uab - norgestimatas/etinilestradiolis - tabletės - 250 µg/35 µg - norgestimate and ethinylestradiol
lindynette
gedeon richter plc - gestodenas/etinilestradiolis - dengtos tabletės - 75 µg/20 µg; 75 µg/30 µg - gestodene and ethinylestradiol
loette
pfizer europe ma eeig - levonorgestrelis/etinilestradiolis - plėvele dengtos tabletės - 100 µg/20 µg - levonorgestrel and ethinylestradiol
copiktra
secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - antinavikiniai vaistai - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies. follicular lymphoma (fl) that is refractory to at least two prior systemic therapies.